These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24806617)

  • 21. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
    Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
    J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation.
    Yew TL; Hung YT; Li HY; Chen HW; Chen LL; Tsai KS; Chiou SH; Chao KC; Huang TF; Chen HL; Hung SC
    Cell Transplant; 2011; 20(5):693-706. PubMed ID: 21176394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases.
    Gil M; Seshadri M; Komorowski MP; Abrams SI; Kozbor D
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):E1291-300. PubMed ID: 23509246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung.
    Zhang J; Chen J; Wo D; Yan H; Liu P; Ma E; Li L; Zheng L; Chen D; Yu Z; Liang C; Peng J; Ren DN; Zhu W
    Clin Cancer Res; 2019 Aug; 25(15):4832-4845. PubMed ID: 31010839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling.
    Feys L; Descamps B; Vanhove C; Vral A; Veldeman L; Vermeulen S; De Wagter C; Bracke M; De Wever O
    Oncotarget; 2015 Sep; 6(29):26615-32. PubMed ID: 26396176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis.
    Zhang Y; Yang P; Sun T; Li D; Xu X; Rui Y; Li C; Chong M; Ibrahim T; Mercatali L; Amadori D; Lu X; Xie D; Li QJ; Wang XF
    Nat Cell Biol; 2013 Mar; 15(3):284-94. PubMed ID: 23396050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.
    De Luca A; Lamura L; Gallo M; Maffia V; Normanno N
    J Cell Biochem; 2012 Nov; 113(11):3363-70. PubMed ID: 22644871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mechanism by which SDF-1β protects cardiac cells from palmitate-induced endoplasmic reticulum stress and apoptosis via CXCR7 and AMPK/p38 MAPK-mediated interleukin-6 generation.
    Zhao Y; Tan Y; Xi S; Li Y; Li C; Cui J; Yan X; Li X; Wang G; Li W; Cai L
    Diabetes; 2013 Jul; 62(7):2545-58. PubMed ID: 23423573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF.
    Zhang P; Dong L; Yan K; Long H; Yang TT; Dong MQ; Zhou Y; Fan QY; Ma BA
    Oncol Rep; 2013 Oct; 30(4):1753-61. PubMed ID: 23863999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer.
    Chang YW; Chen MW; Chiu CF; Hong CC; Cheng CC; Hsiao M; Chen CA; Wei LH; Su JL
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S687-95. PubMed ID: 25047463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PRPF4 is a novel therapeutic target for the treatment of breast cancer by influencing growth, migration, invasion, and apoptosis of breast cancer cells via p38 MAPK signaling pathway.
    Park S; Han SH; Kim HG; Jeong J; Choi M; Kim HY; Kim MG; Park JK; Han JE; Cho GJ; Kim MO; Ryoo ZY; Choi SK
    Mol Cell Probes; 2019 Oct; 47():101440. PubMed ID: 31445970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation.
    Sun Y; Cheng Z; Ma L; Pei G
    J Biol Chem; 2002 Dec; 277(51):49212-9. PubMed ID: 12370187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of SDF1-α expression in tumor microenvironment is associated with aspirin-mediated suppression of the pro-metastasis effect of sorafenib in hepatocellular carcinoma.
    Lu L; Lu M; Pei Y; Chen J; Qin L; Zhu W; Jia H
    Acta Biochim Biophys Sin (Shanghai); 2015 Dec; 47(12):988-96. PubMed ID: 26607439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
    Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
    PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
    Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
    Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling.
    Kalpana G; Figy C; Yeung M; Yeung KC
    Sci Rep; 2019 Nov; 9(1):16351. PubMed ID: 31705019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. REX-1 expression and p38 MAPK activation status can determine proliferation/differentiation fates in human mesenchymal stem cells.
    Bhandari DR; Seo KW; Roh KH; Jung JW; Kang SK; Kang KS
    PLoS One; 2010 May; 5(5):e10493. PubMed ID: 20463961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.
    Li LZ; Zhang CZ; Liu LL; Yi C; Lu SX; Zhou X; Zhang ZJ; Peng YH; Yang YZ; Yun JP
    Carcinogenesis; 2014 Feb; 35(2):469-78. PubMed ID: 24085799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways.
    Maroufi NF; Vahedian V; Akbarzadeh M; Mohammadian M; Zahedi M; Isazadeh A; Pouremamali F; Taefehshokr S; Heidari M; Rashidi M; Nouri M
    Breast Cancer; 2020 Jul; 27(4):613-620. PubMed ID: 32026267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.